BRPI0611400B1 - formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas - Google Patents

formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas Download PDF

Info

Publication number
BRPI0611400B1
BRPI0611400B1 BRPI0611400A BRPI0611400A BRPI0611400B1 BR PI0611400 B1 BRPI0611400 B1 BR PI0611400B1 BR PI0611400 A BRPI0611400 A BR PI0611400A BR PI0611400 A BRPI0611400 A BR PI0611400A BR PI0611400 B1 BRPI0611400 B1 BR PI0611400B1
Authority
BR
Brazil
Prior art keywords
formulations
adhesive
xyloglycan
medical devices
useful
Prior art date
Application number
BRPI0611400A
Other languages
English (en)
Inventor
Giuseppe Bottoni
Maffei Paola
Annalisa Sforzini
Federici Mascia
Carla Caramella
Silvia Rossi
Giuseppe Claudio Viscomi
Original Assignee
Alfasigma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfasigma S.P.A. filed Critical Alfasigma S.P.A.
Publication of BRPI0611400A2 publication Critical patent/BRPI0611400A2/pt
Publication of BRPI0611400A8 publication Critical patent/BRPI0611400A8/pt
Publication of BRPI0611400B1 publication Critical patent/BRPI0611400B1/pt
Publication of BRPI0611400B8 publication Critical patent/BRPI0611400B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)

Abstract

formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas. o objeto da invenção são formulações muco-adesivas e de liberação controlada consistindo em soluções aquosas contendo 0,05% a 5% em peso de um polímero purificado natural tendo estrutura xiloglicano e 10% a 70% em peso de glicerol. estas formulações são apropriadas para aplicação sobre membranas de mucosas humanas, tais como membranas de mucosas nasal, oral e vaginal, como agentes umectantes e amaciantes ou como sistema de liberação farmacêutica. ainda objetos da invenção são formulações farmacêuticas e dispositivos médicos apropriados para a aplicação a membranas de mucosas humanas, contendo as formulações muco-adesivas e de liberação controlada junto com ingredientes ativos e excipientes.
BRPI0611400A 2005-06-06 2006-06-01 formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas BRPI0611400B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000388A ITBO20050388A1 (it) 2005-06-06 2005-06-06 Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
ITBO2005A000388 2005-06-06
PCT/EP2006/005240 WO2006131262A1 (en) 2005-06-06 2006-06-01 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations

Publications (4)

Publication Number Publication Date
BRPI0611400A2 BRPI0611400A2 (pt) 2010-09-08
BRPI0611400A8 BRPI0611400A8 (pt) 2017-12-26
BRPI0611400B1 true BRPI0611400B1 (pt) 2020-04-28
BRPI0611400B8 BRPI0611400B8 (pt) 2021-05-25

Family

ID=36954507

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0611400A BRPI0611400B8 (pt) 2005-06-06 2006-06-01 formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas

Country Status (22)

Country Link
US (3) US20090081133A1 (pt)
EP (1) EP1898876B1 (pt)
JP (1) JP5118633B2 (pt)
KR (1) KR101337578B1 (pt)
CN (2) CN102079794B (pt)
AT (1) ATE418324T1 (pt)
BR (1) BRPI0611400B8 (pt)
CA (1) CA2604768C (pt)
CY (1) CY1108875T1 (pt)
DE (1) DE602006004451D1 (pt)
DK (1) DK1898876T3 (pt)
ES (1) ES2318756T3 (pt)
IL (1) IL186655A (pt)
IT (1) ITBO20050388A1 (pt)
MX (1) MX2007015074A (pt)
NO (1) NO338991B1 (pt)
PL (1) PL1898876T3 (pt)
PT (1) PT1898876E (pt)
RU (1) RU2403012C2 (pt)
SI (1) SI1898876T1 (pt)
UA (1) UA90507C2 (pt)
WO (1) WO2006131262A1 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1698630T1 (sl) 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
US20090068122A1 (en) * 2007-09-06 2009-03-12 Shira Pilch Dentifrice Compositions for Treating Xerostomia
EA201071166A1 (ru) * 2008-04-11 2011-06-30 Сембайосиз Джинетикс, Инк. Контролируемое высвобождение активных агентов из олеосом
US8691286B2 (en) * 2009-01-27 2014-04-08 Teleflex Medical Incorporated Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
IT1397132B1 (it) * 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
AU2011257388B2 (en) 2010-05-24 2016-10-13 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
WO2011147767A1 (en) 2010-05-24 2011-12-01 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of microbial infections
US9220675B2 (en) 2010-09-09 2015-12-29 Mary Kay Inc. Topical skin care formulations comprising plant extracts
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9091622B2 (en) 2011-12-20 2015-07-28 Exxonmobil Upstream Research Company Capillary-based calibration standards for measurement of permeability
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2014042875A1 (en) 2012-09-12 2014-03-20 Boston Scientific Scimed, Inc. Adhesive stent coating for anti-migration
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
ITMI20130960A1 (it) * 2013-06-11 2014-12-12 Novintethical Pharma Sagl Composizioni a base di xiloglucano per il trattamento di disturbi gastrointestinali
US20150094266A1 (en) * 2013-06-11 2015-04-02 Novintethical Pharma, SA Xyloglucan and protein compositions for the treatment of intestinal disorders
ITMI20132103A1 (it) * 2013-12-16 2015-06-17 Novintethical Pharma Sagl Composizioni topiche nasali contenenti xiloglucani per uso come decongestionanti
ES2675305T3 (es) * 2014-04-15 2018-07-10 Novintethical Pharma Sa Composiciones a base de xiloglucano y proteínas para el tratamiento de trastornos intestinales
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
EP3174542A4 (en) 2014-07-29 2018-01-03 TherapeuticsMD, Inc. Transdermal cream
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
EP3103438B1 (en) 2015-06-11 2018-11-14 Novintethical Pharma SA Topical nasal compositions containing xyloglucans for use as decongestans
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CA3023797A1 (en) 2016-05-31 2017-12-07 Novintethical Pharma Sa Compositions for the treatment of intestinal disorders
CA3025863A1 (en) * 2016-07-08 2018-01-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Pharmaceutical composition comprising benzydamine
IT201700108526A1 (it) 2017-09-28 2019-03-28 Alfasigma Spa Composizioni orali per il trattamento del refluso gastroesofageo.
JP7601802B2 (ja) * 2019-06-21 2024-12-17 アルファシグマ ソシエタ ペル アチオニ キシログルカン及びアルコールを含む、活性成分の制御放出のためのゲル形態の医薬組成物
IT202100010802A1 (it) 2021-05-03 2022-11-03 Alfasigma Spa Formulazione solida mucoadesiva comprendente probiotici per uso nella prevenzione e nel trattamento di disbiosi orale.
JP7851113B2 (ja) * 2021-12-08 2026-04-24 Ｍｐ五協フード＆ケミカル株式会社 噴霧用組成物
CN114306237A (zh) * 2022-01-06 2022-04-12 江苏爱朋医疗科技股份有限公司 一种鼻腔护理喷雾剂及其制备方法和应用
WO2026078513A1 (en) 2024-10-07 2026-04-16 Labomar S.P.A. Formulation comprising a mucoadhesive, washout-resistant and film- forming association

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69012955T2 (de) * 1989-10-31 1995-02-09 Columbia Laboratories, Inc., Miami, Fla. Verfahren zur Feuchthaltung von Gewebe und Mittel dazu.
JPH07289179A (ja) * 1994-04-28 1995-11-07 Dainippon Pharmaceut Co Ltd 米飯用改質剤
US6271001B1 (en) * 1995-03-23 2001-08-07 Bio Polymers Pty. Ltd. Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications
JP3909095B2 (ja) * 1995-04-11 2007-04-25 大日本住友製薬株式会社 可逆的熱ゲル化剤
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US6245354B1 (en) * 1996-02-13 2001-06-12 Dainippon Pharmaceutical Co., Ltd. Drug delivery system using galactoxyloglucan
JPH11152207A (ja) * 1997-11-20 1999-06-08 Shiseido Co Ltd 化粧料
JPH10259142A (ja) * 1997-03-14 1998-09-29 Shiseido Co Ltd 化粧料
ES2252865T3 (es) * 1997-09-26 2006-05-16 Noven Pharmaceuticals, Inc. Composiciones bioadhesivas y metodos para la administracion topica de agentes activos.
TR200402446T4 (tr) * 2001-05-03 2004-12-21 Farmigea S.P.A. Servik aşınmanın tedavisi için sükralfatın kullanımı.
DE10344126A1 (de) * 2003-09-24 2005-04-21 Henkel Kgaa Wasserlöslicher Schmelzklebstoff
US20050214230A1 (en) * 2004-03-23 2005-09-29 J. B. Chemicals & Pharmaceuticals Ltd. Novel stomatological gel

Also Published As

Publication number Publication date
IL186655A (en) 2010-12-30
RU2403012C2 (ru) 2010-11-10
EP1898876B1 (en) 2008-12-24
JP5118633B2 (ja) 2013-01-16
ITBO20050388A1 (it) 2006-12-07
BRPI0611400B8 (pt) 2021-05-25
CN101180036B (zh) 2011-07-27
DK1898876T3 (da) 2009-03-02
MX2007015074A (es) 2008-01-24
PT1898876E (pt) 2009-03-05
PL1898876T3 (pl) 2009-06-30
BRPI0611400A2 (pt) 2010-09-08
IL186655A0 (en) 2008-01-20
SI1898876T1 (sl) 2009-04-30
CY1108875T1 (el) 2014-07-02
JP2008542324A (ja) 2008-11-27
BRPI0611400A8 (pt) 2017-12-26
CN102079794A (zh) 2011-06-01
US20130183325A1 (en) 2013-07-18
ATE418324T1 (de) 2009-01-15
EP1898876A1 (en) 2008-03-19
DE602006004451D1 (de) 2009-02-05
KR101337578B1 (ko) 2013-12-09
UA90507C2 (uk) 2010-05-11
ES2318756T3 (es) 2009-05-01
US20120088726A1 (en) 2012-04-12
KR20080016596A (ko) 2008-02-21
RU2007143998A (ru) 2009-07-20
WO2006131262A1 (en) 2006-12-14
US20090081133A1 (en) 2009-03-26
NO338991B1 (no) 2016-11-07
NO20076083L (no) 2007-11-26
CN102079794B (zh) 2012-03-28
CA2604768C (en) 2013-07-30
CA2604768A1 (en) 2006-12-14
CN101180036A (zh) 2008-05-14

Similar Documents

Publication Publication Date Title
BRPI0611400A8 (pt) Formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas
BR0011116A (pt) Usos de uma nsaid que libera no como um sal farmaceuticamente aceitável ou um enanciÈmero do mesmo, e de uma nsaid que libera no e de um inibidor de bomba de próton suscetìvel a ácido ou um sal do mesmo ou um enanciÈmero ou de um sal do enanciÈmero, método para o tratamento de uma infecção bacteriana, e, formulação farmacêutica adequada para uso no tratamento de infecções bacterianas
AR038575A1 (es) Formulacion oftalmica con nueva composicion de goma
BR0113663A (pt) Composições de pelìcula de pectina
BRPI0112962B8 (pt) composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
NO20071354L (no) anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
DE60211464D1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
NO20034323D0 (no) Medisinske aerosolformuleringer
BR9901782A (pt) Forma para dosagem de nefazodona.
BR9908617A (pt) Nitroto inorgânico e ácido orgânico em combinação como uma composição antiviral tópica.
PT1383752E (pt) 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
ECSP066608A (es) Suspensiones acuosas de ciclesonide para nebulización
DE602004016403D1 (de) Topische pharmazeutische Zusammensetzungen enthaltend aktive natürliche Bestandteile zur Verhütung und Behandlung von mucosalen Entzündungprozessen
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
KR20110063434A (ko) 국소 항염증 조합물
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
DE60205905D1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral
BRPI0411702B8 (pt) uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral
CL2008001282A1 (es) Composicion farmaceutica con actividad antimicrobiana que comprende un aminoacidos n halogenado y un agente antiinflamatorio; uso para prevenir o tratar una infeccion de tejidos, donde dicho tejido es ocular, nasal, seno nasal o dermico o una infeccion respiratoria.
BR0112131A (pt) Composições farmacêuticas e métodos para uso
BR0214487A (pt) Composição farmacêutica que compreende uma combinação de metformina e um ácido 4-oxobutanóico, e o uso da mesma para o tratamento de diabetes
BR112015000647A2 (pt) composições orais líquidas e pediátricas que contêm nepadutant

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: ALFASIGMA S.P.A. (IT)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 9/00 , A61K 31/415 , A61K 31/196 , A61K 31/57

Ipc: A61K 47/36 (1990.01), A61K 47/10 (1990.01), A61K 3

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/04/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/06/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25G Requested change of headquarter approved

Owner name: ALFASIGMA S.P.A. (IT)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2777 DE 26-03-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.